Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants

Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants

Erythropoietin (EPO) administration prevents anemia of prematurity and may be associated with a significant increase in the risk of retinopathy of prematurity (ROP) in preterm infants. Nonetheless, early EPO treatment may prevent damage following retinal neovascularization. The aim of this meta-anal...

Full description

Bibliographic Details
Main Authors: Hsin-Hsu Chou, Mei-Yung Chung, Xiao-Guang Zhou, Hung-Chih Lin
Format: Article
Language:English
Published: Elsevier 2017-02-01
Series:Pediatrics and Neonatology
Subjects:
erythropoietin
meta-analysis
retinopathy of prematurity
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957216300638

Internet

http://www.sciencedirect.com/science/article/pii/S1875957216300638

Similar Items